Review: taking Metoprolol tartrate and Magnesium citrate together


Summary

Drug interactions are reported among people who take Metoprolol tartrate and Magnesium citrate together. This review analyzes the effectiveness and drug interactions between Metoprolol tartrate and Magnesium citrate. It is created by eHealthMe based on reports of 2,071 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 46,723 users)

Magnesium Citrate

Magnesium citrate has active ingredients of magnesium. It is often used in constipation. (latest outcomes from Magnesium citrate 973 users)

On Sep, 19, 2016

2,071 people who take Metoprolol Tartrate, Magnesium Citrate are studied.


Number of reports submitted per year:

Metoprolol tartrate and Magnesium citrate drug interactions.

Drug effectiveness over time:

Metoprolol Tartrate:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 33.0% - (2 of 6 people)
  • 2 - 5 years: 33.0% - (1 of 3 people)
  • 5 - 10 years: 33.0% - (2 of 6 people)
  • 10+ years: 66.0% - (2 of 3 people)
  • not specified: 0.0% - (0 of 0 people)
Magnesium Citrate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 40.0% - (2 of 5 people)
  • 6 - 12 months: 28.0% - (2 of 7 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 33.0% - (1 of 3 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Metoprolol Tartrate:
  • female: 50.0% - (8 of 16 people)
  • male: 28.0% - (2 of 7 people)
Magnesium Citrate:
  • female: 41.0% - (5 of 12 people)
  • male: 0.0% - (0 of 7 people)

Drug effectiveness by age:

Metoprolol Tartrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 25.0% - (1 of 4 people)
  • 40-49: 75.0% - (3 of 4 people)
  • 50-59: 100.0% - (3 of 3 people)
  • 60+: 25.0% - (3 of 12 people)
Magnesium Citrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 25.0% - (1 of 4 people)
  • 40-49: 66.0% - (2 of 3 people)
  • 50-59: 66.0% - (2 of 3 people)
  • 60+: 0.0% - (0 of 9 people)

Most common drug interactions over time *:

< 1 month:
  • dehydration
  • renal failure
  • hypotension
  • respiratory failure
  • cytomegalovirus infection
  • hepatic failure
  • mucosal inflammation
  • bk virus infection
  • cystitis haemorrhagic
  • hyperbilirubinaemia
1 - 6 months:
  • stevens-johnson syndrome
  • atrial fibrillation
  • dehydration
  • decreased appetite
  • female genital tract fistula
  • hypoalbuminaemia
  • hypokalaemia
  • pyrexia
  • urinary tract infection
  • anastomotic leak
6 - 12 months:
  • renal failure acute
  • anaemia
  • anxiety aggravated
  • chronic fatigue syndrome
  • coordination impairment
  • dizziness
  • hallucinations, mixed
  • high blood pressure
  • impaired healing
  • loss of employment
1 - 2 years:
  • migraine
  • cerebral haemorrhage
  • death
  • multiple injuries
  • abasia
  • abdominal distension
  • acid reflux
  • adverse event
  • anaemia
  • anosmia
2 - 5 years:
  • constipation
  • gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • intraventricular haemorrhage
  • stomach pain
  • stools - black or tarry
  • upper gastrointestinal haemorrhage
  • atrial flutter
  • cardio-respiratory arrest
  • fatigue
5 - 10 years:
  • anxiety aggravated
  • benign positional vertigo
  • chronic fatigue syndrome
  • constipation
  • coordination impairment
  • dizziness
  • hallucinations, mixed
  • loss of employment
  • loss of libido
  • sleeplessness
10+ years:
  • gastrointestinal haemorrhage
  • palpitations aggravated
  • renal impairment
  • acute respiratory failure
  • anaemia
  • cardio-respiratory arrest
  • febrile neutropenia
  • pulmonary haemorrhage
  • septic shock
  • thrombocytopenia
not specified:
  • dyspnoea
  • pain
  • nausea
  • anaemia
  • diarrhoea
  • fatigue
  • pneumonia
  • asthenia
  • pyrexia
  • anxiety

Most common drug interactions by gender *:

female:
  • nausea
  • pain
  • diarrhoea
  • dyspnoea
  • fatigue
  • anaemia
  • asthenia
  • anxiety
  • atrial fibrillation
  • dizziness
male:
  • anaemia
  • dyspnoea
  • pain
  • pneumonia
  • fatigue
  • oedema peripheral
  • asthenia
  • diarrhoea
  • pyrexia
  • nausea

Most common drug interactions by age *:

0-1:
  • premature baby
10-19:
  • crohn's disease
  • blood creatinine increased
  • cardio-respiratory arrest
  • cartilage injury
  • cerebrovascular accident
  • completed suicide
  • death
  • dissociation
  • drug hypersensitivity
  • foetal exposure during pregnancy
20-29:
  • headache
  • dyspnoea
  • nausea
  • vomiting
  • blood pressure increased
  • anxiety
  • device related infection
  • abdominal pain upper
  • chest pain
  • diarrhoea
30-39:
  • pyrexia
  • renal failure
  • arthralgia
  • drug ineffective
  • anxiety
  • pain
  • ankle fracture
  • arthritis
  • blood thyroid stimulating hormone decreased
  • burning sensation
40-49:
  • pain
  • anxiety
  • diarrhoea
  • headache
  • renal failure acute
  • vomiting
  • dehydration
  • anaemia
  • nausea
  • dyspnoea
50-59:
  • pain
  • diarrhoea
  • fatigue
  • nausea
  • dyspnoea
  • dizziness
  • oedema peripheral
  • anxiety
  • arthralgia
  • hypotension
60+:
  • dyspnoea
  • anaemia
  • nausea
  • atrial fibrillation
  • pneumonia
  • asthenia
  • pain
  • pyrexia
  • fall
  • fatigue

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metoprolol tartrate and Magnesium citrate?

Can you answer these questions?

More questions for: Metoprolol tartrate, Magnesium citrate

You may be interested in these reviews

More reviews for: Metoprolol tartrate, Magnesium citrate

On eHealthMe, Metoprolol tartrate (metoprolol tartrate) is often used to treat high blood pressure. Magnesium citrate (magnesium) is often used to treat constipation. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.